cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
Published 4 years ago • 215 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
2:12
results of a trial comparing cabozantinib and sunitinib in mrcc
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
1:44
dr. choueiri on cabosun trial results in rcc
-
2:34
nivo cabozantinib vs sunitinib for first-line treatment of arcc
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
1:56
checkmate 9er: arcc patients on nivolumab plus cabozantinib achieved deeper responses vs sunitinib
-
6:26
esmo 2016: press brief on results of cabosun trial cabozantinib compared to sunitinib in rcc
-
5:26
mrcc: impact of cabosun and checkmate-214
-
2:32
dr. motzer on sunitinib versus pazopanib in renal cell carcinoma
-
0:55
selecting patients with renal cell carcinoma for adjuvant sunitinib therapy
-
0:56
dr. gupta on the cabosun trial for rcc
-
4:12
cabosun trial of cabozantinib - could it change how we treat frontline rcc?
-
3:09
should sunitinib still be used in the treatment of metstatic kidney cancer?
-
2:02
cabozantinib in mrcc
-
2:17
other trials and combinations to treat renal cell carcinoma
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma